These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32925085)

  • 21. POINT: Is Noninvasive Ventilation Always the Most Appropriate Manner of Long-term Ventilation for Infants With Spinal Muscular Atrophy Type 1? Yes, Almost Always.
    Bach JR
    Chest; 2017 May; 151(5):962-965. PubMed ID: 27989614
    [No Abstract]   [Full Text] [Related]  

  • 22. Nocturnal ventilation in neuromuscular disease--when and how?
    Simonds AK
    Monaldi Arch Chest Dis; 2002; 57(5-6):273-6. PubMed ID: 12814040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy.
    Al-Zaidy S; Pickard AS; Kotha K; Alfano LN; Lowes L; Paul G; Church K; Lehman K; Sproule DM; Dabbous O; Maru B; Berry K; Arnold WD; Kissel JT; Mendell JR; Shell R
    Pediatr Pulmonol; 2019 Feb; 54(2):179-185. PubMed ID: 30548438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Special considerations in the respiratory management of spinal muscular atrophy.
    Schroth MK
    Pediatrics; 2009 May; 123 Suppl 4():S245-9. PubMed ID: 19420154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Respiratory care in spinal muscular atrophy in the new therapeutic era].
    Palomino MA; Castiglioni C
    Rev Chil Pediatr; 2018 Dec; 89(6):685-693. PubMed ID: 30725056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A breakthrough effect of gene replacement therapy on respiratory outcomes in children with spinal muscular atrophy.
    AlNaimi A; Hamad SG; Mohamed RBA; Ben-Omran T; Ibrahim K; Osman MFE; Abu-Hasan M
    Pediatr Pulmonol; 2023 Apr; 58(4):1004-1011. PubMed ID: 36533697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory management of spinal muscular atrophy type 1 patients treated with Nusinersen.
    Menard J; Seferian AM; Fleurence E; Barzic A; Binoche A; Labouret G; Coutier L; Vuillerot C; Bieleu BM; Gomez Garcia de la Banda M; Corvol H; Servais L; Taytard J
    Pediatr Pulmonol; 2022 Jun; 57(6):1505-1512. PubMed ID: 35307979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort.
    Al-Zaidy SA; Kolb SJ; Lowes L; Alfano LN; Shell R; Church KR; Nagendran S; Sproule DM; Feltner DE; Wells C; Ogrinc F; Menier M; L'Italien J; Arnold WD; Kissel JT; Kaspar BK; Mendell JR
    J Neuromuscul Dis; 2019; 6(3):307-317. PubMed ID: 31381526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonrespiratory complications of nusinersen-treated spinal muscular atrophy type 1 patients.
    Lavie M; Rochman M; Sagi L; Yerushalmy Feler A; Ovadia D; Cahal M; Be'er M; Sadot E; Fattal-Valevski A; Amirav I
    Pediatr Pulmonol; 2022 Mar; 57(3):686-694. PubMed ID: 34921596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.
    Finkel RS; Mercuri E; Darras BT; Connolly AM; Kuntz NL; Kirschner J; Chiriboga CA; Saito K; Servais L; Tizzano E; Topaloglu H; Tulinius M; Montes J; Glanzman AM; Bishop K; Zhong ZJ; Gheuens S; Bennett CF; Schneider E; Farwell W; De Vivo DC;
    N Engl J Med; 2017 Nov; 377(18):1723-1732. PubMed ID: 29091570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
    Mendell JR; Al-Zaidy S; Shell R; Arnold WD; Rodino-Klapac LR; Prior TW; Lowes L; Alfano L; Berry K; Church K; Kissel JT; Nagendran S; L'Italien J; Sproule DM; Wells C; Cardenas JA; Heitzer MD; Kaspar A; Corcoran S; Braun L; Likhite S; Miranda C; Meyer K; Foust KD; Burghes AHM; Kaspar BK
    N Engl J Med; 2017 Nov; 377(18):1713-1722. PubMed ID: 29091557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based analysis of survival in spinal muscular atrophy.
    Wijngaarde CA; Stam M; Otto LAM; van Eijk RPA; Cuppen I; Veldhoen ES; van den Berg LH; Wadman RI; van der Pol WL
    Neurology; 2020 Apr; 94(15):e1634-e1644. PubMed ID: 32217777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vital capacity in spinal muscular atrophy.
    Bach JR; Tuccio MC; Khan U; Saporito LR
    Am J Phys Med Rehabil; 2012 Jun; 91(6):487-93. PubMed ID: 22469873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal muscular atrophy: Surviving respiratory failure, intensive care and pursuing creatively fulfilled life.
    Cheng JWCH; Lai KY; Yam SWL; Leung KKY; Lee LPY; Hon KLE
    Pediatr Pulmonol; 2022 Jul; 57(7):1799-1801. PubMed ID: 35419994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of goal-directed non-invasive ventilation and mechanical insufflation/exsufflation in spinal muscular atrophy type I.
    Chatwin M; Bush A; Simonds AK
    Arch Dis Child; 2011 May; 96(5):426-32. PubMed ID: 20573738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of spinal muscular atrophy in the United States: a contemporary assessment.
    Droege M; Sproule D; Arjunji R; Gauthier-Loiselle M; Cloutier M; Dabbous O
    J Med Econ; 2020 Jan; 23(1):70-79. PubMed ID: 31322019
    [No Abstract]   [Full Text] [Related]  

  • 37. Risdiplam in Type 1 Spinal Muscular Atrophy.
    Baranello G; Darras BT; Day JW; Deconinck N; Klein A; Masson R; Mercuri E; Rose K; El-Khairi M; Gerber M; Gorni K; Khwaja O; Kletzl H; Scalco RS; Seabrook T; Fontoura P; Servais L;
    N Engl J Med; 2021 Mar; 384(10):915-923. PubMed ID: 33626251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of comprehensive health management on the prognosis of children with type Ⅰ spinal muscular atrophy].
    Ge XS; Qu YJ; Peng XY; Chen Q; Jiao H; Song F
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):398-402. PubMed ID: 32392956
    [No Abstract]   [Full Text] [Related]  

  • 39. Spinal muscular atrophy--type I.
    Hardart MK; Truog RD
    Arch Dis Child; 2003 Oct; 88(10):848-50. PubMed ID: 14500298
    [No Abstract]   [Full Text] [Related]  

  • 40. The changing natural history of spinal muscular atrophy type 1.
    Oskoui M; Levy G; Garland CJ; Gray JM; O'Hagen J; De Vivo DC; Kaufmann P
    Neurology; 2007 Nov; 69(20):1931-6. PubMed ID: 17998484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.